Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last CNY77.65 CNY
Change Today -4.55 / -5.54%
Volume 4.3M
As of 2:33 AM 04/28/15 All times are local (Market data is delayed by at least 15 minutes).

hangzhou tigermed consulti-a (300347) Snapshot

Open
CNY82.74
Previous Close
CNY82.20
Day High
CNY82.95
Day Low
CNY75.37
52 Week High
04/23/15 - CNY95.50
52 Week Low
05/19/14 - CNY26.55
Market Cap
16.7B
Average Volume 10 Days
4.9M
EPS TTM
CNY0.59
Shares Outstanding
215.0M
EX-Date
--
P/E TM
131.6x
Dividend
CNY0.20
Dividend Yield
0.26%
Current Stock Chart for HANGZHOU TIGERMED CONSULTI-A (300347)

Related News

No related news articles were found.

hangzhou tigermed consulti-a (300347) Related Businessweek News

No Related Businessweek News Found

hangzhou tigermed consulti-a (300347) Details

Hangzhou Tigermed Consulting Co., Ltd. operates as a contract research organization in the People’s Republic of China. The company offers clinical trial services in various therapeutic areas; and clinical trial planning, management, and implementation services. It also provides data management, biological statistics, professional medical translation, medical device clinical development, pharmacovigilance, and staffing services, as well as customized regulatory services for pharmaceuticals, biological products, and medical devices. In addition, the company engages in the lab service and management for drug clinical trials. The company has strategic alliances with Medidata Solutions, Inc. and Simcere. Hangzhou Tigermed Consulting Co., Ltd. was founded in 2004 and is headquartered in Hangzhou, the People’s Republic of China.

Founded in 2004

hangzhou tigermed consulti-a (300347) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

hangzhou tigermed consulti-a (300347) Key Developments

Hangzhou Tigermed Consulting Co., Ltd., 2014 Earnings Call, Apr 17, 2015

Hangzhou Tigermed Consulting Co., Ltd., 2014 Earnings Call, Apr 17, 2015

Hangzhou Tigermed Consulting Co., Ltd. Proposes Amendments to the Articles of Association

Hangzhou Tigermed Consulting Co., Ltd. announced that at the Annual General Meeting to be held on May 06, 2015, the company will propose amendments to the articles of association of the company.

Hangzhou Tigermed Consulting Co., Ltd. Proposes Cash Dividend

Hangzhou Tigermed Consulting Co., Ltd. proposed cash dividend of CNY 2.00 per ten shares (tax included) under the profit distribution proposal for 2014.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
300347:CH CNY77.65 CNY -4.55

300347 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
PAREXEL International Corp $70.13 USD +2.64
WuXi PharmaTech Cayman Inc $40.35 USD +0.73
View Industry Companies
 

Industry Analysis

300347

Industry Average

Valuation 300347 Industry Range
Price/Earnings 100.0x
Price/Sales 27.7x
Price/Book 20.5x
Price/Cash Flow 141.1x
TEV/Sales 27.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact HANGZHOU TIGERMED CONSULTI-A, please visit www.tigermed.net. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.